Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial)

Int J Nurs Stud. 2018 Apr:80:67-75. doi: 10.1016/j.ijnurstu.2017.12.010. Epub 2017 Dec 29.

Abstract

Background: Anxiety, depressive and somatoform disorders are highly prevalent and cause a huge economic burden. A nurse-led collaborative care intervention has been set up in order to improve self-management of patients with these mental disorders in primary care in Hamburg, Germany. The aim of this study was to determine the cost-utility of this nurse-led intervention from the health care payer perspective.

Methods: This analysis was part of a 12-month cluster-randomized controlled trial aiming to increase perceived self-efficacy of primary care patients with anxiety, depressive or somatic symptoms by collaborative nurse-led self-management support compared with routine care. A cost-effectiveness analysis using quality-adjusted life years was performed. Net-monetary benefit regressions adjusted for baseline differences for different willingness-to-pay thresholds were conducted and cost-effectiveness acceptability curves were constructed.

Results: In total, n = 325 patients (intervention group: n = 134; control group: n = 191) with a mean age of 40 from 20 primary care practices were included in the analysis. The adjusted differences in quality-adjusted life years and mean total costs between intervention group and control group were +0.02 and +€1145, respectively. Neither of the two differences was statistically significant. The probability for cost-effectiveness of the complex nurse-led intervention was 49% for a willingness-to-pay of €50,000 per additional quality-adjusted life year. The probability for cost-effectiveness did not exceed 65%, independent of the willingness-to-pay.

Conclusion: The complex nurse-led intervention promoting self-management for primary care patients with anxiety, depressive or somatic symptoms did not prove to be cost-effective relative to routine care from a health care payer perspective.

Keywords: Anxiety disorders; Collaborative care; Cost-utility analysis; Depressive disorders; Nurses; Primary care; Quality-adjusted life years; Somatoform disorders.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anxiety / nursing
  • Anxiety / therapy*
  • Case-Control Studies
  • Cluster Analysis
  • Cooperative Behavior*
  • Cost-Benefit Analysis*
  • Depression / nursing
  • Depression / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nurse-Patient Relations*
  • Patient Education as Topic / economics*
  • Patient Education as Topic / methods*
  • Quality-Adjusted Life Years
  • Self Care*
  • Somatoform Disorders / nursing
  • Somatoform Disorders / therapy*
  • Surveys and Questionnaires